A 39-amino-acid triple agonist peptide engineered to interact with the GIP, GLP-1, and glucagon receptors, designed for use in metabolic and endocrinology research settings.
This advanced investigational compound is part of a next-generation class of multi-target peptide structures being studied for their role in energy balance, glucose regulation, and body composition modulation within controlled clinical and preclinical research environments.
Built for precision and stability, this peptide represents a premium-grade research compound intended for laboratory use only. Its multi-receptor activity profile makes it a valuable tool for studying complex metabolic pathways and the interplay between appetite signaling, insulin response, and energy expenditure.
Key Features:
- 39 amino acid peptide structure
- Triple agonist activity: GIP, GLP-1, and glucagon receptors
- Designed for metabolic and endocrine pathway research
- High-purity, research-grade formulation
- Suitable for in vitro and preclinical studies only
Research Use Only:
This compound is intended strictly for laboratory research purposes and is not approved for human consumption or medical use.
Premium Research Peptide for advanced metabolic science applications.
Reviews
There are no reviews yet.